Learning Outcomes
Development of the ability to recognise und understand the main interpretative issues related to the taught provisions, to use appropriate interpretative methods for solving them, to present und critically evaluate the opinions supported about them in science and jurisprudence and to apply correctly the provisions in the framework of practical exercises.
Course Content (Syllabus)
This particular section mainly analyzes Regulation 536/2014 on clinical trials of medicinal products intended for humans, which introduces a pan-European licensing process through a new Clinical Trial Data Portal Gateway and distinguishes between clinical studies from clinical trials, as well as minimally invasive clinical trials. The basic guiding principles of this new EU initiative are interpreted in depth, exhaustively and multidisciplinary, such as the supremacy of participants' interests and respect for human rights (human dignity, integrity of person, rights of children and persons in need of increased protection, freedom of science) ensuring validity and reliability, the system of researcher or sponsor responsibility, which remains within the jurisdiction of the Member States and regulated by the respective national laws, the consent of participants or persons acting on their behalf, after thorough information, the protection of personal data. Special reference and analysis in this section will be made to the issue of clinical studies and trials of vaccines to deal with the Covid-19 pandemic from a legal, medical and bioethical point of view.
Additional bibliography for study
Επιπρόσθετη βιβλιογραφία καθώς και άλλο βοηθητικό υλικό (διαγράμματα παραδόσεων, πρακτικά παραδόσεων, αποφάσεις νομολογίας, φροντιστηριακές ασκήσεις, σεμιναριακό υλικό) παρέχεται κατά τη διάρκεια των μαθημάτων από τον εκάστοτε διδάσκοντα / διδάσκουσα ή αναρτάται στο e-learning.